search
Back to results

Proactive Palliative Care for Patients With Ventricular Assist Devices (VAD) and Their Families

Primary Purpose

Heart Failure, End-stage Disease

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Palliative Care
Usual Care
Sponsored by
Icahn School of Medicine at Mount Sinai
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Heart Failure focused on measuring Heart Failure, Ventricular Assist Device, Palliative Care

Eligibility Criteria

21 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • age >21 years
  • fluent in English
  • have a caregiver/family member who is willing to be enrolled and who is also fluent in English
  • consistent and reliable access to a phone

Exclusion Criteria:

  • non English-speaking

Sites / Locations

  • Icahn School of Medicine at Mount Sinai

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Other

Arm Label

Palliative Care

Control

Arm Description

Receive ongoing counseling and symptom assessment as well as clarification and documentation of goals of care, starting before implantation and continuing throughout the course of the study. Intervention patients will also be followed by the inpatient palliative care consultation service when hospitalized for their initial VAD implantation and during any subsequent hospitalizations as needed

Usual Care

Outcomes

Primary Outcome Measures

Pain Assessment - change at 1 year from baseline
change in pain from baseline to 1 year, using the Memorial Symptom Assessment Scale

Secondary Outcome Measures

Satisfaction with care - change at 1 year from baseline
changes in satisfaction with care from baseline to 1 year as measured with validated scales for satisfaction with care.
PROMIS anxiety scale - change at 1 year from baseline
changes in anxiety from baseline to 1 year as measured by the PROMIS anxiety scale
PROMIS depression scale - change at 1 year from baseline
changes in depression measured from baseline to 1 year as measured by the PROMIS depression scale

Full Information

First Posted
August 15, 2011
Last Updated
September 5, 2013
Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
National Institute on Aging (NIA), The Greenwall Foundation, Emily Davie and Joseph S. Kornfeld Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT01427634
Brief Title
Proactive Palliative Care for Patients With Ventricular Assist Devices (VAD) and Their Families
Official Title
Randomized Controlled Trial of Proactive Palliative Care for Patients With Ventricular Assist Devices and Their Families
Study Type
Interventional

2. Study Status

Record Verification Date
September 2013
Overall Recruitment Status
Completed
Study Start Date
July 2011 (undefined)
Primary Completion Date
July 2012 (Actual)
Study Completion Date
July 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
National Institute on Aging (NIA), The Greenwall Foundation, Emily Davie and Joseph S. Kornfeld Foundation

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The primary aim of the study is to provide "proof of concept" to demonstrate that patients with Ventricular Assist Devices (VADs) and caregivers are willing to be enrolled in a randomized trial of palliative care and that such a study is feasible. Secondary aims include demonstrating improvement in symptoms (physical and psychological) for intervention patients and their caregivers as compared to control patients and caregivers. The investigators will also examine differences in utilization of healthcare services, mortality, and completion of advance directives between intervention and control patients.
Detailed Description
A ventricular assist device is an implanted mechanical device which augments the pumping function of the heart's ventricles. The number of patients with VADs is expected to increase in an exponential manner in the years to come as device technology improves and continues to show a survival benefit. The investigators propose a randomized controlled trial of a proactive palliative care intervention for patients with VADs and their caregivers. Patients randomized to palliative care will receive ongoing counseling and symptom assessment as well as clarification and documentation of goals of care, starting before implantation and continuing throughout the course of the study. The intervention is delivered primarily in the outpatient setting by a palliative care nurse practitioner. Intervention patients will also be followed by the inpatient palliative care consultation service when hospitalized for their initial VAD implantation and during any subsequent hospitalizations as needed. Control patients will receive usual care as provided by the VAD clinical team. Data collection will be performed by a research assistant at Mount Sinai (blinded to randomization) who conducts baseline assessments in person, and then follow-up assessments over the phone. The primary aim of the study is to provide "proof of concept" to demonstrate that patients and caregivers are willing to be enrolled in a randomized trial of palliative care and that such a study is feasible. Secondary aims include demonstrating improvement in symptoms (physical and psychological) for intervention patients and their caregivers as compared to control patients and caregivers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure, End-stage Disease
Keywords
Heart Failure, Ventricular Assist Device, Palliative Care

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care Provider
Allocation
Randomized
Enrollment
18 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Palliative Care
Arm Type
Active Comparator
Arm Description
Receive ongoing counseling and symptom assessment as well as clarification and documentation of goals of care, starting before implantation and continuing throughout the course of the study. Intervention patients will also be followed by the inpatient palliative care consultation service when hospitalized for their initial VAD implantation and during any subsequent hospitalizations as needed
Arm Title
Control
Arm Type
Other
Arm Description
Usual Care
Intervention Type
Behavioral
Intervention Name(s)
Palliative Care
Intervention Description
Receive ongoing counseling and symptom assessment as well as clarification and documentation of goals of care, starting before implantation and continuing throughout the course of the study. Intervention patients will also be followed by the inpatient palliative care consultation service when hospitalized for their initial VAD implantation and during any subsequent hospitalizations as needed
Intervention Type
Other
Intervention Name(s)
Usual Care
Intervention Description
Receive usual care as provided by the VAD clinical team.
Primary Outcome Measure Information:
Title
Pain Assessment - change at 1 year from baseline
Description
change in pain from baseline to 1 year, using the Memorial Symptom Assessment Scale
Time Frame
baseline (within 2 weeks of enrollment) and at 1 year after implantment
Secondary Outcome Measure Information:
Title
Satisfaction with care - change at 1 year from baseline
Description
changes in satisfaction with care from baseline to 1 year as measured with validated scales for satisfaction with care.
Time Frame
at baseline (within 2 weeks of enrollment) and at 1 year after implantment
Title
PROMIS anxiety scale - change at 1 year from baseline
Description
changes in anxiety from baseline to 1 year as measured by the PROMIS anxiety scale
Time Frame
at baseline (within 2 weeks of enrollment) and at 1 year after implantment
Title
PROMIS depression scale - change at 1 year from baseline
Description
changes in depression measured from baseline to 1 year as measured by the PROMIS depression scale
Time Frame
at baseline (within 2 weeks of enrollment) and at 1 year after implantment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age >21 years fluent in English have a caregiver/family member who is willing to be enrolled and who is also fluent in English consistent and reliable access to a phone Exclusion Criteria: non English-speaking
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nathan E. Goldstein, MD
Organizational Affiliation
Icahn School of Medicine at Mount Sinai
Official's Role
Principal Investigator
Facility Information:
Facility Name
Icahn School of Medicine at Mount Sinai
City
New York
State/Province
New York
ZIP/Postal Code
10029
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
20019324
Citation
WRITING GROUP MEMBERS; Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Roger VL, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010 Feb 23;121(7):e46-e215. doi: 10.1161/CIRCULATIONAHA.109.192667. Epub 2009 Dec 17. No abstract available. Erratum In: Circulation. 2010 Mar 30;121(12):e260. Stafford, Randall [corrected to Roger, Veronique L]. Circulation. 2011 Oct 18;124(16):e425.
Results Reference
background
PubMed Identifier
20123242
Citation
Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Ulisney KL, Baldwin JT, Young JB. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant. 2010 Jan;29(1):1-10. doi: 10.1016/j.healun.2009.10.009. No abstract available.
Results Reference
background

Learn more about this trial

Proactive Palliative Care for Patients With Ventricular Assist Devices (VAD) and Their Families

We'll reach out to this number within 24 hrs